ATOVASTRIN EZ F is an advanced lipid-lowering medication designed to manage complex cholesterol disorders effectively. It combines Atorvastatin Calcium (10 mg), Fenofibrate (160 mg), and Ezetimibe IP (10 mg)—three well-established agents that work through different mechanisms to control cholesterol and triglyceride levels. This triple-action formulation is particularly beneficial for patients with mixed dyslipidemia, where both cholesterol and triglycerides are elevated. ATOVASTRIN EZ F helps reduce the risk of cardiovascular diseases such as heart attack and stroke, making it a trusted option in long-term heart health management. Uses ATOVASTRIN EZ F is prescribed for the treatment and prevention of lipid abnormalities, including: High LDL (bad cholesterol) levels Elevated triglycerides Low HDL (good cholesterol) Mixed dyslipidemia Prevention of cardiovascular complications in high-risk patients It is often recommended for patients who do not achieve adequate lipid control with single or dual therapy and require a comprehensive approach. Benefits ATOVASTRIN EZ F offers multiple therapeutic benefits due to its synergistic formulation: Triple-action lipid control: Lowers LDL cholesterol, triglycerides, and improves HDL levels Reduces cardiovascular risk: Helps prevent heart attack, stroke, and atherosclerosis Improves overall lipid profile: Targets cholesterol production, absorption, and fat metabolism Convenient combination therapy: Reduces pill burden, improving treatment adherence Effective for diabetic and metabolic syndrome patients: Especially useful in patients with co-existing lipid and sugar abnormalities Regular use, along with lifestyle modifications, supports long-term heart and vascular health. Dosage The dosage of ATOVASTRIN EZ F should be determined by a physician based on the patient’s lipid profile, medical history, and treatment response. Usually taken once daily, preferably in the evening or as advised by the doctor Should be swallowed whole with water Can be taken with or without food Regular monitoring of lipid levels and liver function is advised Patients should not adjust the dose or discontinue the medication without consulting their healthcare provider. Side Effects Most patients tolerate ATOVASTRIN EZ F well. However, some may experience mild to moderate side effects such as: Headache or dizziness Nausea, indigestion, or abdominal discomfort Muscle pain or weakness Increased liver enzymes (usually reversible) Rare but serious side effects may include severe muscle problems or liver issues. Any unexplained muscle pain, dark urine, or persistent fatigue should be reported to a doctor immediately. Precautions and Warning Before starting ATOVASTRIN EZ F, the following precautions should be considered: Liver disorders: Use with caution in patients with liver disease Kidney impairment: Dose adjustments may be required Pregnancy and breastfeeding: Not recommended unless clearly prescribed Alcohol consumption: Excessive intake should be avoided Drug interactions: Inform your doctor about all medications being taken Routine blood tests are recommended to ensure safety during long-term therapy. A heart-healthy diet, regular exercise, and weight control enhance treatment effectiveness. Conclusion ATOVASTRIN EZ F is a powerful and reliable solution for managing complex lipid disorders. By combining Atorvastatin Calcium 10 mg, Fenofibrate 160 mg, and Ezetimibe IP 10 mg, it delivers comprehensive cholesterol and triglyceride control while reducing cardiovascular risk. When used under medical supervision along with lifestyle modifications, ATOVASTRIN EZ F plays a crucial role in protecting heart health and improving overall quality of life.
| Active ingredient | Atorvastatin Calcium (10 mg), Fenofibrate (160 mg), and Ezetimibe IP (10 mg) |
| Brand Name | ATOVASTRIN EZ F |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Packaging size | 10x10 Tablets |
| Dosage | As Directed By The Physician |
| Storage | Store In A Cool & Dry Place |
| Country of origin | INDIA |